Electrophysiologic and immunopathologic correlates in Guillain–Barré syndrome subtypes

References

• Hughes RAC, Rees JH. Clinical and epidemiologic features of Guillain–Barré syndrome. J. Infect. Dis.176(Suppl. 2), S92–S98 (1997).
   PubMed Web of Science ®Google Scholar
• Willison HJ. The immunobiology of Guillain–Barré syndromes. J. Periph. Nerv. Syst.10(2), 94–112 (2005).
   PubMed Web of Science ®Google Scholar
• Burns TM. Guillain–Barré syndrome. Semin. Neurol.28(2), 152–157 (2008).
   PubMedGoogle Scholar
• Hughes RAC, Swan AV, Raphael JC, Annane D, van Koningsveld R, van Doorn PA. Immunotherapy for Guillain–Barré syndrome: a systematic review. Brain130(9), 2245–2257 (2007).
   PubMed Web of Science ®Google Scholar
• Hadden RDM, Cornblath DR, Hughes RAC et al. Electrophysiological classification of Guillain–Barré syndrome: clinical associations and outcome. Ann. Neurol.44(5), 780–788 (1998).
   PubMed Web of Science ®Google Scholar
• Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann. Neurol.27(Suppl.), S21–S24 (1990).
   PubMed Web of Science ®Google Scholar
• Gold R, Hartung HP, Toyka KW. Animal models for autoimmune disorders of the nervous system. Mol. Med. Today6(2), 88–91 (2000).
   PubMedGoogle Scholar
• Hafer-Macko CE, Sheikh KA, Li CY et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann. Neurol.39(5), 625–635 (1996).
   PubMed Web of Science ®Google Scholar
• Gordon PH, Wilbourn AJ. Early electrodiagnostic findings in Guillain–Barré syndrome. Arch. Neurol.58(6), 913–917 (2001).
   PubMedGoogle Scholar
• Vucic S, Cairns KD, Black KR, Chong PS, Cros D. Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy. Clin. Neurophysiol.115(10), 2329–2335 (2004).
   PubMed Web of Science ®Google Scholar
• Brown FW, Snow R. Patterns and severity of conduction abnormalities in Guillain–Barré syndrome. J. Neurol. Neurosurg. Psychiatry54, 768–774 (1991).
   PubMed Web of Science ®Google Scholar
• Cappellen-Smith C, Kuwabara S, Lin CS, Mogyros I, Burke D. Activity dependent hyperpolarization and conduction block in chronic inflammatory demyelinating polyneuropathy. Ann. Neurol.48(6), 826–832 (2000).
   PubMedGoogle Scholar
• Kaji R. Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies. Muscle Nerve27(3), 285–296 (2003).
   PubMed Web of Science ®Google Scholar
• Uncini A, England JD, Rhee EK, Duckett SW, Sumner AJ. Tellurium-induced demyelination: an electrophysiological and morphological study. Muscle Nerve11(8), 871–879 (1988).
   PubMedGoogle Scholar
• Sumner AJ, Saida K, Saida T, Silberberg DH, Asbury AK. Acute conduction block associated with experimental antiserum-mediated demyelination of peripheral nerve. Ann. Neurol.11(5), 469–477 (1982).
   PubMedGoogle Scholar
• Clouston PDE, Kiers L, Zuniga C, Cros D. Quantitative analysis of the compound muscle action potential in early acute inflammatory demyelinating polyneuropathy. Electroencephalogr. Clin. Neurophysiol.93(4), 245–254 (1994).
   PubMedGoogle Scholar
• Rees JH, Gregson NA, Hughes RAC. Anti-ganglioside GM1 antibody in Guillain–Barré syndrome and their relationship to Campylobacter jejuni infection. Ann. Neurol.38(5), 809–816 (1995).
   PubMed Web of Science ®Google Scholar
• Kalita J, Misra UK, Das M. Neurophysiologic criteria in the diagnosis of different clinical types of Guillain–Barré syndrome. J. Neurol. Neurosurg. Psychiatry79(3), 289–293 (2008).
   PubMed Web of Science ®Google Scholar
• Kushnir M, Klein C, Pollak L. Rabey JM. Evolving pattern of Guillain–Barré syndrome in a community hospital in Israel. Acta Neurol. Scand.117(5), 347–350 (2008).
   PubMedGoogle Scholar
• Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N. Axonal Guillain–Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter liejuni infection in Japan. Ann. Neurol.48(4), 624–631 (2000).
   PubMed Web of Science ®Google Scholar
• Nachamkin I, Arzate Barbosa P, Ung H et al. Patterns of Guillain–Barré syndrome in children: results from a Mexican population. Neurology69(17), 1665–1671 (2007).
   PubMed Web of Science ®Google Scholar
• Ho TW, Mishu B, Li CY et al. Guillain–Barré syndrome in northen China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain118(3), 597–605 (1995).
   PubMed Web of Science ®Google Scholar
• McKhann GR, Cornblath DR, Griffin JW et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann. Neurol.33(4), 333–342 (1993).
   PubMed Web of Science ®Google Scholar
• Visser LH, van der Meché FGA, van Doorn J et al. Guillain–Barré syndrome without sensory loss (acute motor neuropathy): a subgroup with specific clinical, electrodiagnostic and laboratory features. Brain118(4), 841–847 (1995).
   PubMedGoogle Scholar
• Hiraga A, Kuwabara S, Ogawara K et al. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain–Barré syndrome. Neurology64(5), 856–860 (2005).
   PubMed Web of Science ®Google Scholar
• Yuki N, Hirata K. Preserved tendon reflexes in Campylobacter neuropathy. Ann. Neurol.43(4), 546–547 (1998).
   PubMed Web of Science ®Google Scholar
• Kuwabara S, Ogawara K, Koga M, Mori M, Hattori T, Yuki N. Hyperreflexia in Guillain–Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody. J. Neurol. Neurosurg. Psychiatry67(2), 180–184 (1999).
   PubMed Web of Science ®Google Scholar
• Kuwabara S, Nakata M, Sung JY et al. Hyperreflexia in axonal Guillain–Barré syndrome subsequent to Campylobacter jejuni enteritis. J. Neurol. Sci.199(1–2), 89–92 (2002).
   PubMed Web of Science ®Google Scholar
• Yuki N, Susuki K, Koga M et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain–Barré syndrome. Proc. Natl Acad. Sci. USA101(31), 11404–11409 (2004).
   PubMed Web of Science ®Google Scholar
• Caporale CM, Capasso M, Luciani M et al. Experimental axonopathy induced by immunization with Campylobacter lejuni lipopolysaccharide from a patient with Guillain–Barré syndrome. J. Neuroimmunol.174(1–2), 12–20 (2006).
   PubMed Web of Science ®Google Scholar
• Griffin JW, Li CY, Ho TW et al. Guillain–Barré syndrome in northen China: the spectrum of neuropathological changes in clinically defined cases. Brain118(3), 577–595 (1995).
   PubMed Web of Science ®Google Scholar
• Hafer-Macko C, Hsieh S-T, Li CY et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann. Neurol.40(4), 635–644 (1996).
   PubMed Web of Science ®Google Scholar
• Albers JW, Donofrio PD, McGonagle TK. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyneuropathy. Muscle Nerve8(6), 528–539 (1985).
   PubMed Web of Science ®Google Scholar
• Lugaresi A, Ragno M, Torrieri F, Di Guglielmo G, Fermani P, Uncini A. Acute motor axonal neuropathy with hig titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis. J. Neurol. Sci.147(2), 193–200 (1997).
   PubMedGoogle Scholar
• Kuwabara S, Ogawara K, Mirawa S et al. Sensory nerve conduction in demyelinating and axonal Guillain–Barré syndrome. Eur. Neurol.51(4), 196–198 (2004).
   PubMedGoogle Scholar
• Ho TW, Hsiek ST, Nachamkin I et al. Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology48(3), 717–724 (1997).
   PubMedGoogle Scholar
• Brown WF, Feasby TE, Hahn AF. The electrophysiological changes in the acute “axonal” form of Guillain–Barré syndrome. Muscle Nerve16(2), 200–205 (1993).
   PubMed Web of Science ®Google Scholar
• Uncini A, Capasso M. Acute motor conduction block neuropathy followed by axonal degeneration and poor recovery. Neurology67(3), 543 (2006).
   PubMedGoogle Scholar
• Kuwabara S, Yuki N, Koga M et al. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain–Barré syndrome. Ann. Neurol.44(2), 202–208 (1998).
   PubMed Web of Science ®Google Scholar
• Kuwabara S, Mori M, Ogawara K et al. Axonal involvement at the common entrapment sites in Guillain–Barré syndrome with IgG anti-GM1 antibody. Muscle Nerve22(7), 840–845 (1999).
   PubMedGoogle Scholar
• Kuwabara S, Ogawara K, Mizobuchi K et al. Isolated absence of F waves and proximal axonal dysfunction in Guillain–Barré syndrome with anti-ganglioside antibodies. J. Neurol. Neurosurg. Psychiatry68(2), 191–195 (2000).
   PubMedGoogle Scholar
• Capasso M, Caporale CM, Pomilio F, Gandolfi P, Lugaresi A, Uncini A. Acute motor conduction block neuropathy: another Guillain–Barré syndrome variant. Neurology61(5), 617–622 (2003).
   PubMed Web of Science ®Google Scholar
• White JR, Sachs GM, Gilchrist JM. Multifocal motor neuropathy with conduction block and Campylobacter jejuni. Neurology46(2), 562–563 (1996).
   PubMed Web of Science ®Google Scholar
• Sugie K, Murata K, Ikoma K, Suzumura A, Takayanagi T. A case of acute multifocal motor neuropathy with conduction block after Campylobacter jejuni enteritis. Rinsho Shinkeigaku38(1), 42–45 (1998).
   PubMedGoogle Scholar
• Corcia P, Beaume A, Guennoc AM, de Toffol B, Preud’homme JL, Autret A. Acute demyelinating motor neuropathy: an atypical form of the Guillain–Barré syndrome? Rev. Neurol. (Paris)155(8), 596–597 (1999).
   PubMedGoogle Scholar
• Susuki K, Johkura K, Yuki N, Hasegawa O, Kuroiwa Y. Rapid resolution of nerve conduction blocks after plasmapheresis in Guillain–Barré syndrome associated with anti-GM1b IgG antibody. J. Neurol.248(2), 148–150 (2001).
   PubMedGoogle Scholar
• Rajabally YA, Strens LHA, Abbott RJ. Acute motor conduction block neuropathy followed by axonal degeneration and poor recovery. Neurology66(2), 287–288 (2006).
   PubMedGoogle Scholar
• Takigawa T, Yasuda H, Kikkawa R, Shigeta Y, Saida T, Kitasato H. Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated fibers. Ann. Neurol.37(4), 436–442 (1995).
   PubMed Web of Science ®Google Scholar
• Hirota N, Kaji R, Bostock H et al. The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons. Brain120(12), 2159–2169 (1997).
   PubMed Web of Science ®Google Scholar
• Weber F, Rüdel R, Aulkemeyer P, Brinkmeier H. Anti-GM1 antibodies can block neuronal voltage-gated sodium channels. Muscle Nerve23(9), 1414–1420 (2000).
   PubMed Web of Science ®Google Scholar
• Oda K, Araki K, Totoki T, Shibasaki H. Nerve conduction study of human tetrodoxication. Neurology39(5), 743–745 (1989).
   PubMed Web of Science ®Google Scholar
• Cong NH, Tuan le TQ. Electrodiagnosis in puffer fish poisoning. Electromyogr. Clin. Neurophysiol.46(5), 291–294 (2006).
   PubMedGoogle Scholar
• Yuki N, Yamada M, Koga M et al. Animal model of axonal Guillain–Barré syndrome induced by sensitization with GM1 ganglioside. Ann. Neurol.49(6), 712–720 (2001).
   PubMed Web of Science ®Google Scholar
• Susuki K, Rasband M, Tohyama K et al. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J. Neurosci.27(15), 3956–3967 (2007).
   PubMed Web of Science ®Google Scholar
• Kuwabara S, Mori M, Ogawara K, Hattori T, Yuki N. Indicators of rapid recovery in Guillain Barré syndrome. J. Neurol. Neurosurg. Psychiatry70(4), 560–562 (2001).
   PubMedGoogle Scholar
• Hiraga A, Mori M, Ogawara K et al. Recovery patterns and long term prognosis for axonal Guillain–Barré syndrome. J. Neurol. Neurosurg. Psychiatry76(5), 719–722 (2005).
   PubMed Web of Science ®Google Scholar
• Tamura N, Kuwabara S, Misawa S et al. Time course of axonal degeneration in acute motor axonal neuropathy. Muscle Nerve35(6), 793–795 (2007).
   PubMed Web of Science ®Google Scholar
• Yuki N, Saperstein DS. Axonal Guillain–Barré syndrome subtypes: do we need more splitting ? Neurology61(5), 598–599 (2003).
   PubMedGoogle Scholar
• Feasby TE, Gilbert JJ, Brown WF, Bolton CF, Hahn AF, Koopman WF. An acute axonal form of Guillain–Barré polyneuropathy. Brain109(6), 1115–1126 (1986).
   PubMed Web of Science ®Google Scholar
• Feasby TE, Hahn AF, Brown WF, Bolton CF, Gilbert JJ, Koopman WF. Severe degeneration in acute Guillain–Barré syndrome evidence of two different mechanisms. J. Neurol. Sci.116(2), 185–192 (1993).
   PubMed Web of Science ®Google Scholar
• Kuwabara S. Guillain–Barré syndrome. Curr. Neurol. Neurosci. Rep.7(1), 57–62 (2007).
   PubMed Web of Science ®Google Scholar
• Yuki N, Kuwabra S, Koga M, Hirata K. Acute motor axonal neuropathy and acute motor–sensory neuropathy share a common immunological profile. J. Neurol. Sci.168(2), 121–126 (1999).
   PubMed Web of Science ®Google Scholar
• Griffin JW, Li CY, Ho TW et al. Pathology of the motor–sensory axonal Guillain–Barré syndrome. Ann. Neurol.39(1), 17–28 (1996).
   PubMed Web of Science ®Google Scholar
• Alam TA, Chaudhry V, Cornblath DR. Electrophysiological studies in the Guillain–Barré syndrome: distinguishing subtypes by published criteria. Muscle Nerve21(10), 1275–1279 (1998).
   PubMed Web of Science ®Google Scholar
• Raphël JC, Chevret S, Hughes RAC, Annane D. Plasma exchange for Guillain–Barré syndrome. Cocharane Database Syst. Rev.2, CD002063 (2001).
   Google Scholar
• Hughes RAC, Raphael JC, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain–Barré syndrome. Cocharane Database Syst. Rev.1, CD002063 (2006).
   Google Scholar
• Jacobs BC, van Doorn PA, Schmitz PI et al.Campylobacter jejuni infections and anti-GM1 antibodies in Guillain–Barré syndrome. Ann. Neurol.40(2), 181–187 (1996).
   PubMed Web of Science ®Google Scholar
• Yuki N, Ang CW, Koga M et al. Clinical features and response to treatment in Guillain–Barré syndrome associated with antibodies to GM1b ganglioside. Ann. Neurol.47(3), 314–321 (2000).
   PubMed Web of Science ®Google Scholar
• Townson K, Boffey J, Nicholl D et al. Solid phase immunoadsorbtion for therapeutic and analytical studies on neuropathy-associated anti-GM1 antibodies. Glycobiology17(3), 294–303 (2007).
   PubMed Web of Science ®Google Scholar
• Tagawa Y, Yuki N, Hirata K. Ability to remove immunoglobulins and anti-ganglioside antibodies by plasma exchange, double-filtration plasmapheresis and immunoadsorption. J. Neurol. Sci.157(1), 90–95 (1998).
   PubMed Web of Science ®Google Scholar
• Jacobs BC, O’Hanlon GM, Bullens RW, Veitch J, Plomp JJ, Willison HJ. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding. Brain126(10), 2220–2234 (2003).
   PubMed Web of Science ®Google Scholar
• Nishimoto Y, Koga M, Kamijo M, Hirata K, Yuki N. Immunoglobulin improves a model of acute motor axonal neuropathy by preventing axonal degeneration. Neurology62(11), 1939–1944 (2004).
   PubMed Web of Science ®Google Scholar
• Buchwald B, Zhang G, Vogt-Eisele AK et al. Anti-ganglioside antibodies alter presynaptic release and calcium influx. Neurobiol. Dis.28(1), 113–121 (2008).
   Google Scholar
• Lehmann HC, Lopez PH, Zhang G et al. Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model. J. Neurosci.27(1), 27–34 (2007).
   PubMedGoogle Scholar
• Wanschitz J, Maier H, Lassman H, Budka H, Berger T. Distinct time pattern of complement activation and cytotoxic T cell response in Guillain–Barré syndrome. Brain126(9), 2034–2042 (2003).
   PubMed Web of Science ®Google Scholar
• Halstead SK, O’Hanlon GM, Humphreys PD et al. Anti-disialoside antibodies kill perysinaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain127(9), 2109–2123 (2004).
   PubMed Web of Science ®Google Scholar
• Halstead SK, Humphreys PD, Goodfellow JA, Wagner ER, Smith RAG, Willison HJ. Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome. Ann. Neurol.58(2), 203–210 (2005).
   PubMed Web of Science ®Google Scholar
• Halstead SK, Humphreys PD, Zitman FM, Hamer J, Plomp JJ, Willison HJ. C5 inhibitor rEV576 protects against neural injury in an in vitro mouse model of Miller Fisher syndrome. J. Periph. Nerv. Syst.13(3), 228–235 (2008).
   PubMed Web of Science ®Google Scholar
• Halstead SK, Zitman FMP, Humphreys PD et al. Eculizimab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain131(5), 1197–1208 (2008).
   PubMed Web of Science ®Google Scholar
• Brodsky RA, Young NS, Antonioli E et al. Multicenter Phase 3 study of the complement inhibitor eculizimab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood111(4), 1840–1847 (2008).
   PubMed Web of Science ®Google Scholar
• Phongsisay V, Susuki K, Matsuno K et al. Complement inhibitor prevents disruption of sodium channel clusters in a rabbit model of Guillain–Barré syndrome. J. Neuroimmunol.205(1–2), 101–104 (2008).
   PubMed Web of Science ®Google Scholar
• Asbury AK, Cornblath DR. Preserved tendon reflexes in Campylobacter neuropathy [reply]. Ann. Neurol.43(4), 547 (1998).
   Google Scholar
• van der Meché FGA, Meulstee J, Vermeulen M, Kievit A. Patterns of conduction failure in the Guillain–Barré syndrome. Brain111(2), 405–416 (1988).
   PubMedGoogle Scholar
• Podnar S, Vodusek DB. Hyperreflexia in a patient with motor axonal Guillain–Barré syndrome. Eur. J. Neurol.7(6), 727–730 (2000).
   PubMed Web of Science ®Google Scholar
• Gong Y, Tagawa Y, Lunn MP et al. Localization of major gangliosides in the PNS: implications for immune neuropathies. Brain125(11), 2491–2506 (2002).
   PubMed Web of Science ®Google Scholar
• De Angelis MV, di Muzio A, Lupo S, Gambi D, Uncini A, Lugaresi A. Anti-GD1a antibodies from an acute motor axonal neuropathy patient selectively bind to motor nerve fibre nodes of Ranvier. J. Neuroimmunol.121(1–2), 72–89 (2001).
   Google Scholar
• Lopez PHH, Zhang G, Bianchet MA, Schnaar RL, Sheikh KA. Structural requirements of anti-GD1a antibodies determine their target specificity. Brain131(7), 1926–1939 (2008).
   PubMed Web of Science ®Google Scholar
• Nobile-Orazio E, Cappellari A, Priori A. Multifocal motor neuropathy: current concepts and controversies. Muscle Nerve31(6), 663–680 (2005).
   PubMed Web of Science ®Google Scholar
• Yuki N, Kuwabara S. Axonal GBS syndrome: carbohydrate mimicry and pathophysiology. J. Periph. Nerv. Syst.12(4), 238–249 (2007).
   PubMedGoogle Scholar